| Thu, 20 Sep 2018 14:34:39: | Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report
|
| Thu, 20 Sep 2018 14:23:53: | Allergan adds actor Scott Eastwood to Alzheimer's effort for even more celebrity firepower
|
| Thu, 20 Sep 2018 13:54:52: | Allergan, eyeing Asia for growth, pours $14.7M into first medical aesthetics center in China
|
| Thu, 20 Sep 2018 13:33:38: | Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
|
| Thu, 20 Sep 2018 13:11:31: | Racing with Merck, Pfizer wins FDA 'breakthrough' tag for 20-valent pneumococcal vaccine
|
| Thu, 20 Sep 2018 12:18:47: | Novartis' Alcon adds online training portal to supplement in-person eyecare education centers
|
| Wed, 19 Sep 2018 14:48:26: | U.K. court invalidates Gilead's Truvada patent extension, allowing PrEP generics
|
| Wed, 19 Sep 2018 13:39:00: | Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag: report
|
| Wed, 19 Sep 2018 13:23:50: | England's cost watchdogs nix Novartis' Kymriah for adults
|
| Tue, 18 Sep 2018 22:22:29: | SEC hands Clovis $20M penalty for allegedly misleading investors
|
| Tue, 18 Sep 2018 20:10:11: | Amgen leaves celeb spokeswoman Blythe Danner behind in newest Prolia ad
|
| Tue, 18 Sep 2018 18:47:51: | In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales
|
| Tue, 18 Sep 2018 17:01:27: | Say hello to Sophia, Novo Nordisk's new online chatbot, available 24/7 for diabetes questions
|
| Tue, 18 Sep 2018 14:00:29: | AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data
|
| Tue, 18 Sep 2018 13:34:32: | Johnson & Johnson's talc supplier inks 11th-hour settlement in California mesothelioma case: report
|
| Tue, 18 Sep 2018 13:29:03: | Novartis melanoma combination wins key thumbs-up from cost watchdog NICE after Opdivo shut out
|
| Tue, 18 Sep 2018 12:54:44: | GlaxoSmithKline expands Canada plant, adds production of topical pain reliever
|
| Mon, 17 Sep 2018 19:43:02: | Scientists weigh Zika vaccine challenge study after case count plummets: report
|
| Mon, 17 Sep 2018 15:26:21: | Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production; Merck not as lucky
|
| Mon, 17 Sep 2018 14:36:47: | With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?
|
| Mon, 17 Sep 2018 13:37:17: | Pfizer 'all in' on advancing next-generation pneumococcal vaccine candidate: CFO
|
| Mon, 17 Sep 2018 13:27:04: | Sanofi, Regeneron pad Dupixent’s case in adolescent eczema ahead of key asthma decision
|
| Mon, 17 Sep 2018 12:49:08: | Teva, chasing Amgen's Aimovig, scores much-needed FDA approval for migraine drug Ajovy
|
| Mon, 17 Sep 2018 02:22:54: | With EpiPen competitors bearing down, can Mylan maintain its lead?
|
| Sun, 16 Sep 2018 18:42:59: | House quashes Senate amendment to force drug price inclusion in pharma TV ads
|
